X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16) 16
index medicus (15) 15
aged (13) 13
male (13) 13
middle aged (13) 13
oncology (13) 13
female (12) 12
adult (10) 10
aged, 80 and over (9) 9
hematology (8) 8
treatment outcome (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
dasatinib (7) 7
multiple myeloma - drug therapy (7) 7
benzamides (6) 6
dexamethasone (6) 6
imatinib mesylate (6) 6
abridged index medicus (5) 5
antibodies, monoclonal, humanized - administration & dosage (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
chronic myelogenous leukemia (5) 5
chronic myeloid leukemia (5) 5
cytotoxicity (5) 5
dexamethasone - administration & dosage (5) 5
dosage and administration (5) 5
drug therapy (5) 5
elotuzumab (5) 5
lenalidomide (5) 5
multiple myeloma (5) 5
pyrimidines - administration & dosage (5) 5
adolescent (4) 4
antibodies, monoclonal, humanized - adverse effects (4) 4
drug resistance, neoplasm (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (4) 4
medicine, general & internal (4) 4
monoclonal antibodies (4) 4
monoclonal-antibody (4) 4
pyrimidines - adverse effects (4) 4
pyrimidines - therapeutic use (4) 4
recurrence (4) 4
survival (4) 4
thalidomide - administration & dosage (4) 4
thalidomide - analogs & derivatives (4) 4
therapy (4) 4
thiazoles - adverse effects (4) 4
animals (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
bcr-abl (3) 3
bortezomib (3) 3
clinical trials (3) 3
combination (3) 3
cs1 (3) 3
cytogenetic responses (3) 3
electrophoresis (3) 3
fusion proteins, bcr-abl - antagonists & inhibitors (3) 3
interference (3) 3
leukemia (3) 3
leukemia, myeloid, chronic-phase - drug therapy (3) 3
medical research (3) 3
mice (3) 3
multicenter (3) 3
multiple myeloma - mortality (3) 3
open-label (3) 3
plus dexamethasone (3) 3
protein kinase inhibitors - adverse effects (3) 3
safety and security measures (3) 3
serum-protein (3) 3
thiazoles - administration & dosage (3) 3
trial (3) 3
acute lymphoblastic leukemia (2) 2
advanced solid tumors (2) 2
analysis (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
article (2) 2
camptothecin - administration & dosage (2) 2
camptothecin - analogs & derivatives (2) 2
cancer (2) 2
care and treatment (2) 2
chimeric antigen receptor (2) 2
chimeric antigen receptor t cell (2) 2
chronic lymphoblastic leukemia (2) 2
chronic-phase (2) 2
dexamethasone - adverse effects (2) 2
dexamethasone - therapeutic use (2) 2
diagnosis (2) 2
diffuse large b cell lymphoma (2) 2
disease progression (2) 2
disease-free survival (2) 2
docetaxel (2) 2
dose-response relationship, drug (2) 2
drug administration schedule (2) 2
drug resistance (2) 2
efficacy (2) 2
escalation (2) 2
follow-up (2) 2
follow-up studies (2) 2
hematology, oncology and palliative medicine (2) 2
imatinib (2) 2
interferon-alpha (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 24, pp. 2260 - 2270
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2006, Volume 354, Issue 24, pp. 2531 - 2541
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 7, pp. 621 - 631
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2017, Volume 178, Issue 6, pp. 896 - 905
Journal Article
International Journal of Hematology, ISSN 0925-5710, 3/2017, Volume 105, Issue 3, pp. 326 - 334
Journal Article
Journal Article
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2016, Volume 175, Issue 3, pp. 448 - 456
Journal Article
Clinical Lymphoma, Myeloma & Leukemia, ISSN 2152-2650, 2016, Volume 16, Issue 3, pp. 129 - 138
Journal Article
Cancer, ISSN 0008-543X, 07/2009, Volume 115, Issue 13, pp. 2912 - 2921
Journal Article